NIOX Group PLC Asset Resilience Ratio
NIOX Group PLC asset resilience ratio. NIOX Group PLC (NIOX) has an Asset Resilience Ratio of 2.63% as of June 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of NIOX Group PLC to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of NIOX Group PLC (2013–2017)
Asset resilience ratio of NIOX Group PLC from 2013 to 2017. This chart shows how NIOX Group PLC's Asset Resilience Ratio has changed over time. Read NIOX current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down NIOX Group PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see NIOX Group PLC assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 0% |
| Short-term Investments | GBX10.00 Million | 2.63% |
| Total Liquid Assets | GBX10.00 Million | 2.63% |
Asset Resilience Insights
- Limited Liquidity: NIOX Group PLC maintains only 2.63% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
NIOX Group PLC Industry Peers by Asset Resilience Ratio
Compare NIOX Group PLC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Vitrolife AB
ST:VITR |
Medical Devices | 7.27% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085 |
Medical Devices | 7.69% |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298 |
Medical Devices | 2.82% |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580 |
Medical Devices | 10.74% |
|
TAIDOC TECHNOLOGY CORP
TW:4736 |
Medical Devices | 23.03% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 3.90% |
NIOX Group PLC Asset Resilience Ratio by Year (2013–2017)
NIOX Group PLC asset resilience ratio by year from 2013 to 2017. The table below shows the annual Asset Resilience Ratio data for NIOX Group PLC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 3.73% | GBX15.00 Million ≈ $1.83K |
GBX402.40 Million ≈ $48.96K |
0.00pp |
| 2017-12-30 | 3.73% | GBX15.00 Million ≈ $1.83K |
GBX402.40 Million ≈ $48.96K |
-2.26pp |
| 2016-12-31 | 5.99% | GBX20.00 Million ≈ $2.43K |
GBX334.10 Million ≈ $40.65K |
0.00pp |
| 2016-12-30 | 5.99% | GBX20.00 Million ≈ $2.43K |
GBX334.10 Million ≈ $40.65K |
-1.74pp |
| 2015-12-31 | 7.73% | GBX37.80 Million ≈ $4.60K |
GBX489.20 Million ≈ $59.52K |
0.00pp |
| 2015-12-30 | 7.73% | GBX37.80 Million ≈ $4.60K |
GBX489.20 Million ≈ $59.52K |
-70.53pp |
| 2014-12-31 | 78.25% | GBX156.90 Million ≈ $19.09K |
GBX200.50 Million ≈ $24.40K |
0.00pp |
| 2014-12-30 | 78.25% | GBX156.90 Million ≈ $19.09K |
GBX200.50 Million ≈ $24.40K |
+59.73pp |
| 2013-12-31 | 18.53% | GBX7.05 Million ≈ $857.42 |
GBX38.03 Million ≈ $4.63K |
0.00pp |
| 2013-12-30 | 18.53% | GBX7.05 Million ≈ $857.42 |
GBX38.03 Million ≈ $4.63K |
-- |
About NIOX Group PLC
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide … Read more